308
Participants
Start Date
November 10, 2020
Primary Completion Date
October 20, 2021
Study Completion Date
December 31, 2021
Tocilizumab
Tocilizumab infusion 8mg/kg/dose - Intravenous single dose.
Heparin - Therapeutic dosage
Intravenous Non-Fractional Heparine (HNF) starting at 18UI/kg/h adjusted according to a nomogram to achieve an Activated Partial Thromboplastin Time (ATTP) from 1.5 To 2.0 times the reference Value; or Low Molecular Weight Heparin (LMWH) subcutaneous dosage of 1mg/kg per dose every 12 hours
Heparin - Prophylactic dosage
Subcutaneous Non-Fractional Heparine 5000U every 8 hours OR Subcutaneous Low Molecular Weight (LMWH) 40mg/day.
Fundação São Francisco Xavier, Ipatinga
UNIMED Varginha, Varginha
Universidade Federal de Sergipe, Aracaju
Conselho Nacional de Desenvolvimento Científico e Tecnológico
OTHER_GOV
University of Sao Paulo
OTHER